News

Ludger Ltd Performs Glycosylation Analysis of HIV-1 Subunits in Collab


TRY IT NOW

Sign up online today & collaborate

or click here to find out more

Ludger Ltd Performs Glycosylation Analysis of HIV-1 Subunits in Collaboration with the University of Oxford

 04/05/2016

Oxford, UK – The trimeric HIV type 1 (HIV-1) envelope glycoprotein (Env) is targeted by broadly neutralizing antibodies (bNAbs) produced by the immune system during infection. As part of Ludger’s  collaboration with Dr Max Crispin and his group at the University of Oxford we performed site-specific N-glycosylation analysis of the gp120 and three gp41 subunits of Env.

Using MALDI-MS, LC-MS and HILIC-UPLC our results uncovered a dominance of oligomannose-type glycans and revealed a mosaic of glycan microclusters bearing under-processed glycans, especially in areas covering the gp120 outer domain and at the trimer interfaces.  The information gained from this study will assist in the design of Env-based vaccine immunogens and the work has now been published in Cell Reports :

Title: Site-specific N-glycosylation analysis of HIV-1 Envelope Glycoprotein

For more information contact info@ludger.com


CompanyLudger Ltd
Company Websitehttp://www.ludger.com

© Catalyst Innovation Portal 2019